J. Andersson

发表

Titanium Is a Highly Thrombogenic Biomaterial: Possible Implications for Osteogenesis

B. Nilsson, K. Ekdahl, N. Axén, 1999, Thrombosis and Haemostasis.

Complement-Opsonized HIV-1 toward Dendritic Cells Exposed to Impaired NK Cell Activation and Chemotaxis

J. Andersson, Rada Ellegård, E. Crisci, 2015 .

Heparin molecularly imprinted surfaces for the attenuation of complement activation in blood

K. Ekdahl, M. Alexander, I. Nicholls, 2015 .

Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue

J. Andersson, F. Verreck, M. Maeurer, 2011, Genes and Immunity.

Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation

B. Nilsson, K. Ekdahl, L. Rönnblom, 2004, British journal of haematology.

Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation.

B. Nilsson, K. Ekdahl, J. Andersson, 2001, Biomaterials.

Complement Activation Triggered by Biomaterial Surfaces : Mechanisms and Regulation

J. Andersson, 2003 .

C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase1

Bo Nilsson, B. Nilsson, K. Ekdahl, 2002, The Journal of Immunology.

an Initiating Alternative Pathway Convertase C3 Adsorbed to a Polymer Surface Can Form

K. Ekdahl, J. Andersson, R. Larsson, 2002 .

Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated platelets

John D Lambris, P. Nilsson, B. Nilsson, 2008, Journal of thrombosis and haemostasis : JTH.

Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface.

Bo Nilsson, John D Lambris, B. Nilsson, 2005, Biomaterials.

Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model.

B. Nilsson, K. Ekdahl, J. Andersson, 2006, Journal of biomedical materials research. Part A.

Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro.

B. Nilsson, K. Ekdahl, J. Andersson, 2003, Journal of biomedical materials research. Part A.

Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1

J. Andersson, E. Shankar, Rada Ellegård, 2015, The Journal of Immunology.

Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps

J. Andersson, G. Dellgren, S. Hallhagen, 2015, ASAIO journal.

Heparin surfaces: Impact of immobilization chemistry on hemocompatibility and protein adsorption.

Clayton J. Underwood, R. Biran, J. Andersson, 2014, Journal of biomedical materials research. Part B, Applied biomaterials.

Immune complement activation on polystyrene and silicon dioxide surfaces. Impact of reversible IgG adsorption.

J. Andersson, H. Elwing, M. Berglin, 2005, Molecular immunology.

Quartz crystal microbalance-with dissipation monitoring (QCM-D) for real time measurements of blood coagulation density and immune complement activation on artificial surfaces.

Bo Nilsson, Marcus Andersson, Mattias Berglin, 2005, Biosensors & bioelectronics.

Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1253 Complement Activation Triggered by Biomaterial Surfaces Mechanisms and Regulation

J. Andersson, 2003 .